Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights-Reference-Cited by-同舟云学术

Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights

Published:2021-04-13 Issue:6 Volume:14 Page:661-670
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Raimondo Maria Gabriella¹,Biggioggero Martina²^ORCID,Coletto Lavinia Agra³^ORCID,Ramming Andreas¹,Caporali Roberto²³^ORCID,Favalli Ennio Giulio²^ORCID

Affiliation:

1. Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg and Universitatsklinikum Erlangen, Erlangen, Germany

2. Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute, Milan, Italy

3. Department of Clinical Sciences & Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università Degli Studi Di Milano, Milano, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1913050

Reference86 articles.

1. The Pathogenesis of Rheumatoid Arthritis

2. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007

3. Rheumatoid arthritis

4. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of CEACAM1 expression in cytokine-activated neutrophils using JAK inhibitors;2023-08-14

2. Identification of TUL01101: A Novel Potent and Selective JAK1 Inhibitor for the Treatment of Rheumatoid Arthritis;Journal of Medicinal Chemistry;2022-12-13